Angiogenically effective unit dose of FGF-2 and method of use
Patent Number: 6440934
Date of First Priority Issue: Tuesday October 13th, 1998
Date Issued: Tuesday August 27th, 2002
Assignee: Chiron Corporation (Emeryville, CA)
Inventor: Whitehouse, Martha Jo (San Francisco, CA)
From Class: Expansion
Comments: No comments
This patent covers specific doses of FGF-2 that may be used for the stimulation of angiogenesis.
Angiogenesis stimulation should not be thought of as important only for disease such as angina, but for other disease associated with ischemia such as cerebral palsy, and peripheral vascular disease.
View this patent on the USPTO website.
Added to StemCellPatents.com on Monday October 16th, 2006
Social & Bookmarking:
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.